To facilitate structure-function relationship studies of the V2 vasopressin receptor, a prototypical G s -coupled receptor, we generated V2 receptor-expressing yeast strains (Saccharomyces cerevisiae) that required arginine vasopressin-dependent receptor/G protein coupling for cell growth. V2 receptors heterologously expressed in yeast were unable to productively interact with the endogenous yeast G protein ␣ subunit, Gpa1p, or a mutant Gpa1p subunit containing the C-terminal G␣ q sequence (Gq5). In contrast, the V2 receptor efficiently coupled to a Gpa1p/G␣ s hybrid subunit containing the C-terminal G␣ s sequence (Gs5), indicating that the V2 receptor retained proper G protein coupling selectivity in yeast. To gain insight into the molecular basis underlying the selectivity of V2 receptor/G protein interactions, we used receptor saturation random mutagenesis to generate a yeast library expressing mutant V2 receptors containing mutations within the second intracellular loop. A subsequent yeast genetic screen of about 30,000 mutant receptors yielded four mutant receptors that, in contrast to the wild-type receptor, showed substantial coupling to Gq5. Functional analysis of these mutant receptors, followed by more detailed site-directed mutagenesis studies, indicated that single amino acid substitutions at position Met 145 in the central portion of the second intracellular loop of the V2 receptor had pronounced effects on receptor/G protein coupling selectivity. We also observed that deletion of single amino acids N-terminal of Met 145 led to misfolded receptor proteins, whereas single amino acid deletions C-terminal of Met 145 had no effect on V2 receptor function. These findings highlight the usefulness of combining receptor random mutagenesis and yeast expression technology to study mechanisms governing receptor/G protein coupling selectivity and receptor folding.
Typically, individual members of the superfamily of G protein-coupled receptors (GPCRs) 1 efficiently interact only with a subset of the many different G proteins present in mammalian cells (1) (2) (3) (4) . The spectrum of cellular responses triggered by activation of a specific GPCR is largely determined by the type of G proteins recognized by the activated receptor (1-4). Therefore, elucidating the molecular basis governing the selectivity of receptor/G protein interactions is of fundamental importance for understanding cellular signal transduction. A large body of evidence indicates that multiple receptor regions are involved in G protein coupling and determining the selectivity of G protein recognition (1) (2) (3) (4) . Many studies have shown that the second intracellular loop (i2 loop), the membrane-proximal portions of the third intracellular loop (i3 loop), and the N-terminal segment of the cytoplasmic tail all contain amino acids predicted to play a role in regulating the selectivity of receptor/G protein interactions (1) (2) (3) (4) . These regions/amino acids are likely to define a domain on the intracellular surface of the receptor protein that, following activation of the receptor by an agonist ligand, can productively interact with distinct G protein heterotrimers (5) .
Traditional mutagenesis approaches, including the use of hybrid receptors and alanine scanning mutagenesis techniques, have led to important insights into the structural basis underlying the selectivity of receptor/G protein interactions. However, a major limitation of such classical mutagenesis strategies is that the number of mutant proteins that can be investigated in one study is usually relatively small primarily because of technical reasons and the time and costs needed to generate and analyze large numbers of mutant receptors. Interestingly, yeast has recently emerged as a highly useful host for the in vivo reconstitution of mammalian GPCRs, G proteins, and potentially other related signal transduction proteins (6 -16) . To gain new insights into the mechanisms governing receptor/G protein coupling selectivity, we therefore decided to use receptor random mutagenesis combined with yeast expression technology (6) to isolate mutant receptors with novel G protein coupling properties. Based on the powerful genetic selection procedures that are possible in yeast, this approach would offer the great advantage that thousands of mutant receptors can be analyzed with relative ease without having to rely on specific structural hypotheses or preconceived notions of GPCR function.
For the present work, we used the V2 vasopressin receptor, a peptide receptor that belongs to the subfamily of rhodopsin-like (class I) GPCRs, as a model system. Whereas the structural elements determining the coupling selectivity of biogenic amine receptors have been studied in great detail, much less is known about the molecular basis of peptide receptor/G protein coupling selectivity. In mammalian systems, the V2 vasopressin receptor is selectively coupled to G s triggering the activation of adenylyl cyclase (17) (18) (19) (20) (21) . On the other hand, the structurally closely related V1a and V1b vasopressin receptors and the oxytocin receptor are preferentially linked to G proteins of the G q/11 family, thus stimulating the breakdown of phosphoinositide lipids (19 -21) . The vasopressin/oxytocin peptide receptor family therefore represents an attractive model system to study the molecular mechanisms regulating peptide receptor/G protein coupling selectivity.
Functional analysis of hybrid V1a/V2 vasopressin receptors has previously shown that the ability of the wild-type (wt) V2 receptor to selectively activate G s requires specific structural elements in the i3 loop and the membrane-proximal portion of the cytoplasmic tail (21, 22) . On the other hand, selective coupling of the V1a receptor to G proteins of the G q/11 family was found to be critically dependent on the structural integrity of the i2 loop (21) .
To facilitate structure-function relationship studies of the V2 vasopressin receptor, we initially expressed the human V2 receptor in specifically engineered yeast strains that required ligand-dependent receptor/G protein coupling for cell growth (6, 8 -10, 16) . The individual yeast strains in which the V2 receptor was expressed were genetically identical except for the nature of the expressed G protein ␣ subunit (6, 16) . Yeast growth assays showed that the wt V2 receptor was able to interact efficiently only with a hybrid yeast Gpa1p/mammalian ␣ s subunit containing the C-terminal ␣ s sequence, indicating that the wt V2 receptor retained proper G protein coupling selectivity in yeast.
To take advantage of the powerful genetic selection procedures that are possible in yeast, we used receptor random mutagenesis in an attempt to isolate mutant V2 receptors with novel G protein coupling properties. We anticipated that sequence analysis of such mutant receptors would be useful for better defining the molecular determinants dictating receptor/G protein coupling selectivity. In this initial study, we screened for mutant V2 receptors that would gain the ability to couple to a hybrid yeast Gpa1p/mammalian ␣ q subunit containing the C-terminal ␣ q sequence (Gq5), which is not recognized by the wt V2 receptor.
Specifically, we subjected the i2 loop of the V2 vasopressin receptor to saturation random mutagenesis and generated a yeast library coexpressing individual mutant receptors and the Gq5 G protein. The i2 loop was chosen as the primary target because of our previous observation that this domain largely determines the ability of the V1a vasopressin receptor to selectively interact with G q -type G proteins (21) . Screening of the mutant receptor library in colony growth assays yielded four mutant receptors that gained robust coupling to Gq5. Interestingly, all four mutant receptors contained modifications at position Met 145 in the central portion of the i2 loop. More detailed functional studies, complemented by site-directed mutagenesis studies, indicated that the chemical character of the amino acid present at position 145 in the V2 receptor is a critical determinant of receptor/G protein coupling selectivity. We also noted that the amino acids present at the beginning of the i2 loop immediately adjacent to the third transmembrane helix are essential for proper folding of the V2 receptor.
These results underscore the usefulness of yeast expression technology to study molecular aspects regulating mammalian GPCR function. This is the first study using receptor random mutagenesis, combined with a yeast genetic screen, to study the molecular basis of receptor/G protein coupling selectivity.
EXPERIMENTAL PROCEDURES
Materials-Atropine sulfate, 3-amino-1,2,4-triazole (AT), phenylmethylsulfonyl fluoride, glass beads (425-600 m, acid-washed), and gelatin (porcine skin) were purchased from Sigma. Arginine vasopressin (AVP) was obtained from Calbiochem. The non-peptide V 2 receptor antagonist, SR121463 (1-[4-(N-tert-butylcarbamoyl)-2-methoxybenzene sulfonyl]-5-ethoxy-3-spiro-[4-(2-morpholinoethoxy)cyclohexane]indol-2-one, monophosphate salt) was synthesized at Sanofi-Synthelabo (23) . [ 3 H]SR121463 (47.5 Ci/mmol) (24) and [ 3 H]AVP (81 Ci/mmol) were purchased from PerkinElmer Life Sciences. Yeast nitrogen base, amino acids, and dropout powder were from Bio 101, Inc. All enzymes used for molecular cloning were from New England Biolabs, Inc. The 12CA5 anti-hemagglutinin (HA) mouse monoclonal antibody directed against the HA epitope tag was purchased from Roche Molecular Biochemicals. The anti-mouse IgG antibody conjugated to horseradish peroxidase and nitrocellulose membranes (0.45 m; Hybond-C Extra) were from Amersham Pharmacia Biotech. The enhanced chemiluminescence detection kit was from PerkinElmer Life Sciences. All other chemicals used for SDS-polyacrylamide gel electrophoresis and Western blotting were purchase from Bio-Rad. The p416GPD yeast expression vector was obtained through ATCC.
Construction of Wt and Mutant V2 Vasopressin Receptor Expression Plasmids-A yeast expression plasmid coding for the human V2 vasopressin receptor was constructed using standard molecular biological techniques. A 1.26-kilobase pair EcoRI-XhoI fragment containing the human V2 receptor coding sequence was cut out from the mammalian expression plasmid hV2-pcD (25) and cloned into the corresponding sites in the polylinker of the yeast expression plasmid p416GPD (26, 27) . The p416GPD vector contains the yeast GAPDH (glyceraldehyde-3-phosphate dehydrogenase) promoter and the CYC1 terminator flanking the multiple cloning site (26) . It is a single copy plasmid containing the CEN/ARS element, the URA3 gene as selectable marker for maintenance in yeast, and the Amp gene for propagation in Escherichia coli (26) . The final V2 receptor expression construct hV2-p416GPD contained 6 bp of 5Ј-untranslated sequence (CCCACC) following the EcoRI cloning site. The translation start codon was followed by a 27-bp sequence coding for the HA epitope tag (YPYDVPDYA) (25) . Previous studies showed that the presence of the HA tag did not affect the ligand binding and G protein coupling properties of the V2 vasopressin receptor (21, 25) . The hV2-p416GPD construct also contained 125 bp of 3Ј-untranslated sequence followed by the XhoI cloning site.
Point mutations or deletions were introduced into the hV2-p416GPD construct by standard PCR mutagenesis techniques. The identity of all mutant constructs and the correctness of all PCR-derived coding sequences were verified by dideoxy sequencing of the mutant plasmids.
Construction and Transformation of Yeast Strains-Three different yeast strains, MPY578fc, MPY578q5, and MPY578s5, were used as hosts for the expression of wt and mutant V2 vasopressin receptors (see Fig. 1 ). All three strains were isogenic except for the GPA1 gene coding for the yeast G protein ␣ subunit Gpa1p. The MPY578fc strain, which contains the wt GPA1 gene (6) , has the following genotype: MATa GPA1 far1::LYS2 fus1::FUS1-HIS3 sst2::SST2-G418 r ste2::LEU2 fus2::FUS2-CAN1 ura3 lys2 ade2 his3 leu2 trp1 can1. MPY578q5 and MPY578s5 harbor genomically integrated mutant versions of GPA1 coding for mutant Gpa1 proteins in which the last five amino acids of Gpa1p were replaced with the homologous mammalian G␣ q and G␣ s sequences, respectively (see Fig. 1 ). The construction of the MPY578q5 and MPY578s5 strains has been described previously (16) .
In these strains, deletion of the FAR1 gene allows yeast to grow despite G protein-mediated activation of the pheromone pathway that normally leads to cell cycle arrest (6) . The presence of the FUS1-HIS3 reporter construct makes the production of His3 protein dependent on receptor-mediated activation of the yeast pheromone pathway. As a result, only receptors able to activate coexpressed G proteins will allow growth of auxotrophic (his3) yeast strains in medium lacking histidine. The SST2 gene was disrupted to prevent attenuation of G protein signaling mediated by the GTPase-activating protein activity of Sst2p. The STE2 gene coding for the yeast ␣-factor (pheromone) receptor was deleted to prevent competition with heterologously expressed GPCRs for coexpressed G proteins.
DNA-mediated yeast transformation was carried out by using a lithium acetate method (28) . Receptor-expressing yeast strains were
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generated by transforming MPY578fc, MPY578q5, and MPY578s5 with p416GPD-based receptor expression constructs (see previous section). Transformants were selected on synthetic complete (SC) medium plates lacking uracil. Three individual transformants were chosen from each strain for further analysis.
Library Construction-To construct mutagenized V2 receptors, we used an oligonucleotide-directed random mutagenesis approach. To introduce mutations into the V2 receptor region coding for the i2 loop (see Fig. 2 ), the following oligonucleotide coding for V2 receptor residues 134 -164 was used (Genemed Synthesis, Inc., San Francisco, CA; underlines denote bases doped with 10% non-wild-type nucleotides): 5Ј-ACG CTG GAC CGC CAC CGT GCC ATC TGC CGT CCC ATG CTG GCG TAC CGC CAT GGA AGT GGG GCT CAC TGG AAC CGG CCG GTA CTA GTG GCT TGG-3Ј. The underlined mutagenized sequence codes for amino acids His 138 to Val 160 (see Fig. 2 ). This oligonucleotide was used as a primer for PCR amplification together with oligonucleotide ON2 (5Ј-GGC CCA GCA GTC AGT GAC CCC GCT GCC ACC TTC CAC GTT GCG CTG-3Ј, corresponding in sequence to amino acid codons 180 -194) as antisense primer and hV2-p416GPD as a template. The resulting 183-bp PCR fragment was then used as a template for a second round of PCR using a sense primer that overlapped with the first 12 nucleotides of the mutagenic oligonucleotide (ON30: 5Ј-CAG ATG GTG GGC ATG TAT GCC TCC TCC TAC ATG ATC CTG GCC ATG ACG CTG GAC CGC-3Ј, corresponding in sequence to amino acid codons 119 -137) and ON2 as the antisense primer. The resulting 228-bp PCR fragment contained 57 bp of wt sequence 5Ј and 102 bp of wt sequence 3Ј of the mutagenized sequence, respectively.
A library of yeast clones expressing randomly mutagenized mutant V2 vasopressin receptors was created using a gap-repair protocol (29 -32). Specifically, strain MPY578q5 was cotransformed with the 228-bp mutagenized PCR fragment and a "gapped" version of hV2-p416GPD (0.2 g of purified DNA each). The hV2-p416GPD plasmid was gapped (linearized) by digestion with BstXI, which removed a 52-bp fragment corresponding in sequence to most of the i2 loop from the hV2-p416GPD construct. Following transformation into yeast, the ends of the mutagenized PCR fragment recombined with the homologous ends of the gapped receptor plasmid to regenerate circular receptor expression plasmids.
Receptor Selection-Initially, the MPY578q5-based yeast expression library coding for mutant V2 vasopressin receptors was plated onto uracil-deficient SC medium to select for Uraϩ (plasmid-containing) transformants (plating density, 200 -300 clones/100-mm plate). After incubation of plates for 3 days at 30°C, Uraϩ colonies were transferred via replica plating onto plates containing SC medium lacking both uracil and histidine but containing 0.4 M of the agonist AVP (an AVP stock solution was spread over the plates after the agar had cooled and hardened) and 10 mM AT, a competitive inhibitor of the HIS3 gene product that was added to prevent background growth due to low basal activity of the FUS1 promoter. For control purposes, the primary Uraϩ transformants were also replica plated onto plates containing the identical selection medium but lacking AVP. Under these conditions, an MPY578q5-based yeast strain expressing the wt V2 vasopressin receptor was unable to grow either in the absence or presence of AVP (see Fig. 3 ). However, under the same conditions, an MPY578s5-based yeast strain expressing the wt V2 vasopressin receptor showed robust, agonistdependent growth (see Fig. 3 ). A total of ϳ30,000 yeast clones expressing mutant V2 receptors was screened. Plasmids were isolated from colonies that were able to grow in an AVP-dependent fashion on histidine-deficient medium, amplified in E. coli, and retransformed into MPY578q5 to confirm that the observed growth phenotype was indeed due to a plasmid-borne V2 receptor mutation. Receptor plasmids were then sequenced and, at least in some cases, recreated by PCR-based mutagenesis techniques.
Liquid Bioassays-Yeast strains were cultured overnight in SC medium lacking uracil. Cells were then washed in phosphate-buffered saline (PBS) and diluted to a concentration of 10 5 cells/ml in 4 ml of SC medium (pH 6.9) lacking uracil and histidine. To reduce background growth, 10 mM AT was added to the media. Aliquots of yeast cell suspensions (180 l) were dispensed into wells of sterile 96-well microtiter dishes containing 20 l of serially diluted samples of AVP (final concentration, 10
Ϫ13
-10 Ϫ4 M). The plates were then incubated at 25°C for 3 days under gentle agitation. Yeast growth was monitored during the logarithmic phase of cell growth by recording increases in absorbance at 630 nm using a microplate reader. Assays were conducted in triplicate using three independent transformants. AVP concentrationresponse curves were analyzed using the computer program Kaleidagraph (Synergy Software).
Preparation of Yeast Membranes-Yeast cells from a 1-liter overnight culture (1-2 ϫ 10 7 cells/ml) were collected by centrifugation, and membrane homogenates were prepared by using a glass bead method essentially as described previously (16) . Protein concentrations were determined using the Bradford method (33) with bovine serum albumin as a standard.
Radioligand Binding Assays-Radioligand binding studies were carried out with yeast membrane homogenates prepared as described above from yeast strains expressing wt or mutant V2 vasopressin receptors. Incubations were carried out in a 50 mM Tris-HCl buffer, pH 8.1, containing 2 mM MgCl 2 , 1 mM EDTA, 0.1% bovine serum albumin, 0.1% bacitracin, and increasing concentrations (0.1-15 nM) of the radioligand [ 3 H]SR121463, a selective V2 receptor antagonist (23, 24) . Binding reactions were started by the addition of yeast membranes (100 -200 g of protein/assay tube) and allowed to proceed for 45 min at 25°C. Bound and free ligand were then separated by rapid filtration over Whatman GF/B filters. Nonspecific binding was determined in the presence of 1 M SR121463. Saturation binding data were analyzed by a nonlinear least-squares curve-fitting procedure using the computer program LIGAND (34) .
Western Blot Analysis-For immunoblotting studies, yeast membranes were isolated as described above. Membrane preparations (10 g of protein/sample) were mixed with an equal volume of 2-fold concentrated Laemmli sample buffer (125 mM Tris-HCl (pH 6.8), 20% glycerol, 100 mM dithiothreitol, 4% SDS, and 0.01% bromphenol blue) and incubated at room temperature for 30 min. Proteins were separated on 4 -20% Tris-glycine gradient SDS-polyacrylamide gels and transferred onto nitrocellulose membranes via electroblotting. Membranes were blocked with 0.1% gelatin in PBS containing 0.1% Tween 20 (PBS-T/gelatin; 1 h at room temperature) and then incubated with the mouse 12CA5 (anti-HA) monoclonal antibody (1:16,000 dilution in PBS-T/gelatin; 1 h at room temperature). Bound antibody was detected by incubation with a secondary anti-mouse antibody conjugated to horseradish peroxidase (1:5,000 dilution in PBS-T/gelatin; 1 h at room temperature). After extensive washing of blots with PBS-T/gelatin, proteins were visualized using an enhanced chemiluminescence detection kit.
RESULTS

Functional Expression of the Human V2 Vasopressin
Receptor in Yeast-Our initial goal was to design a strategy that allowed the functional expression of the human V2 vasopressin receptor in yeast. We first cloned the human V2 receptor coding sequence containing an HA epitope tag after the initiating methionine codon (25) into the yeast expression plasmid p416GPD (26) , thus placing V2 receptor expression under the control of the strong yeast GAPDH promoter. The resulting expression plasmid (hV2-p416GPD) was then transformed into yeast strains that were genetically modified such that they required productive receptor/G protein coupling for growth (see "Experimental Procedures" for details). Specifically, the V2 receptor expression construct was transformed into three different yeast strains (MPY578fc, MPY578q5, and MPY578s5; Fig. 1 ) that were isogenic except for the GPA1 gene coding for the endogenous yeast G protein ␣ subunit (6, 16) . MPY578fc contained the wt GPA1 gene, whereas MPY578q5 and MPY578s5 harbored mutant versions of this gene coding for mutant Gpa1 proteins in which the last five amino acids of Gpa1p were replaced with the corresponding residues present in mammalian G␣ q and G␣ s , respectively ( Fig. 1 ). In the following sections, the encoded G␣ subunits are referred to as Gpa1p, Gq5, and Gs5, respectively.
We initially monitored V2 receptor expression via Western blotting analysis using the 12CA5 anti-HA mouse monoclonal antibody as the primary antibody. This analysis revealed two clusters of immunoreactive V2 receptor species, one migrating at ϳ40 kDa and the other one migrating at ϳ80 kDa (Fig. 4) . The ϳ40-kDa receptor cluster corresponds in size to monomeric forms of the V2 receptor, whereas the ϳ80-kDa cluster probably represents dimeric receptor species (35) . It is likely that the heterogeneity of the 40-and 80-kDa bands is caused primarily by heterogeneous glycosylation of the V2 receptor protein (36, 37) . In general, the pattern of immunoreactive V2 receptor bands that we obtained in yeast closely resembled that previ-ously observed in transfected mammalian cells (35) . We also found that all three yeast strains used in this study (MPY578fc, MPY578s5, and MPY578q5) expressed V2 receptor protein at similar levels (data not shown).
To determine the number of functional V2 receptors expressed in yeast, we initially carried out radioligand binding studies with the agonist ligand [ We next examined whether V2 receptors were able to productively couple to coexpressed G proteins in yeast. Specifically, we carried out liquid bioassays in which we tested the ability of the agonist, AVP, to stimulate growth of wt V2 receptor-expressing yeast strains in medium lacking histidine (note that productive receptor/G protein coupling stimulates the production of His3 protein). As shown in Fig. 5 , the V2 receptor was unable to efficiently interact with yeast Gpa1p and the hybrid G protein Gq5. A residual growth response was observed only at the highest AVP concentrations used (Ն0.01 mM). In contrast, the wt V2 receptor was able to interact with coexpressed Gs5 in a highly productive manner. As shown in Fig. 5 , this interaction was characterized by remarkably high AVP potency (EC 50 ϳ6 nM; Table II ). Because Gpa1p, Gq5, and Gs5 differ only in their C-terminal five amino acids (Fig. 1) , these data indicate that the V2 vasopressin receptor can selectively recognize the C-terminal ␣ s residues present in Gs5. Moreover, because the wt V2 receptor selectively couples to G s in mammalian systems (17) (18) (19) (20) (21) , our observations also confirm that the V2 receptor displays the proper G protein coupling preference in yeast. Functional expression of the G q/11 -coupled M 1 , M 3 , and M 5 muscarinic receptors in yeast showed that all three receptors interacted with Gq5 with much greater efficiency than with Gs5 or Gpa1p (16) . This observation indicates that the inability of the wt V2 vasopressin receptor to productively couple to Gq5 (this study) was not an artifact caused by poor expression or improper folding of the Gq5 subunit.
Screening and Selection of Mutant Receptors with Altered G Protein Coupling Properties-To take advantage of the powerful genetic selection procedures that are possible in yeast, we decided to use the yeast expression system to isolate mutant V2 receptors with novel G protein coupling properties. We reported previously (21) that the ability of the V1a vasopressin receptor to selectively recognize G proteins of the G q family critically depends on the structural integrity of the i2 loop. We therefore speculated that it should be possible to isolate mutant V2 receptors containing mutations in the i2 loop that would gain coupling to the Gq5 G protein.
To address this issue, we subjected the i2 loop of the V2 vasopressin receptor (His 138 -Val 160 ; Fig. 2 ) to oligonucleotidebased random mutagenesis. To generate a MPY578q5-based library of yeast clones expressing mutant V2 receptors, we used a gap-repair method (29 -32) that involved cotransformation of a gapped version of hV2-p416GPD with a PCR fragment coding for mutagenized i2 loop sequences into MPY578q5 (see "Experimental Procedures" for details). In vivo recombination events then led to the reformation of circular plasmids coding for mutant V2 vasopressin receptors (29 -32). To assess the quality of the mutant V2 receptor library, we initially recovered and sequenced plasmids from 15 randomly picked colonies grown on uracil-deficient medium to select for transformants containing receptor plasmids. This analysis showed that each clone contained an average of about 6.2 nucleotide changes in good agreement with the predicted mutagenesis rate (10% at the nucleotide level). We also noted that the mutations were evenly distributed throughout the i2 loop sequence.
Colonies that were able to grow on uracil-deficient medium were then replica plated onto medium that lacked both uracil and histidine but contained the agonist AVP (0.4 M) and 10 mM AT (to suppress background growth). Under these conditions, yeast clones expressing the wt V2 receptor failed to grow (Fig. 3) obviously because of the inability of the V2 receptor to interact with Gq5 in a productive fashion. However, under identical conditions, yeast cells coexpressing the wt V2 receptor and Gs5 showed robust agonist-dependent growth (Fig. 3) . Approximately 30,000 primary transformants were replica plated and screened for their ability to grow in an AVP-dependent fashion on the selection medium. Based on the observed mutagenesis rate (about six nucleotide changes per clone), this number of clones should be more than sufficient to include any possible nucleotide substitution within the mutagenized receptor region.
The initial screen yielded 11 colonies that were able to grow on plates containing the selection medium (after replica plating). To confirm that this growth phenotype was dependent on a plasmid-borne V2 receptor mutation, receptor plasmids were recovered from these clones, amplified in E. coli, and retransformed into the MPY578q5 parental yeast strain. Colony assays of the resulting transformants showed that four of the recovered receptor plasmids reproducibly conferred on the MPY578q5 strain the ability to grow, in an AVP-dependent fashion, on plates containing the proper selection medium (Fig.  3) . The mutations contained in the encoded mutant V2 receptors (RM1-RM4) are given in Table I . Three of the four recovered mutant receptors contained three or more mutations within the i2 loop (RM2-RM4), whereas RM1 contained a single amino acid substitution (M145W). Interestingly, all four mutant receptors contained a modification at position Met 145 , either an amino acid substitution (RM1-RM3) or a deletion (RM4). In fact, the M145⌬/L146W mutation contained in RM4 is identical with a M145W/L146⌬ mutation ( Table I) .
Characterization of the G Protein Coupling Properties of the RM1-RM4 Mutant V2 Receptors in Yeast Liquid
Bioassays-To study the G protein coupling properties of the recovered RM1-RM4 mutant receptors in greater detail, we next carried out liquid bioassays to examine the ability of these mutant receptors to interact with Gq5, Gs5, or yeast Gpa1p. As expected based on the colony screen, all four mutant receptors gained considerable coupling to Gq5 (E max ϳ60 -80%) as compared with the wt V2 receptor that showed only residual coupling to Gq5 (Fig. 6A and Table II ). However, similar to the wt receptor, the RM1-RM4 mutant receptors retained the ability to interact with Gs5 in a highly efficient manner and showed little or no coupling to yeast Gpa1p ( Fig. 6B and Table II) .
Substitutions at Position Met 145 Have Pronounced Effects on the G Protein Coupling Profile of the V2 Vasopressin Receptor-
One of the four mutant receptors (RM1) recovered from the initial colony screen harbored a single M145W point mutation, and two of the recovered mutant receptors (RM2 and RM3) contained an M145L substitution in addition to other point mutations (Table I) . To exclude the possibility that RM1 harbored additional mutations outside the region that was subjected to random mutagenesis and sequencing (i2 loop and adjacent transmembrane domains), we recreated a V2(M145W) mutant receptor via site-directed mutagenesis. In addition, to examine whether the M145L substitution was sufficient to confer on the V2 receptor the ability to interact with Gq5, we also created a mutant V2 receptor construct that contained the M145L substitution as the only mutation. The V2(M145W) and V2(M145L) receptor constructs were transformed into the MPY578q5 strain and then examined for their ability to activate Gq5 in yeast liquid bioassays. As shown in Fig. 7A , both mutant receptors gained significant coupling to Gq5 (for AVP EC 50 and E max values, see Table II ) as compared with the wt receptor that showed only residual activity. [ 3 H]SR121463 saturating binding studies showed that the V2(M145W) and V2(M145L) constructs yielded B max values that were not significantly different from the corresponding wt receptor value (Table III) , indicating that the observed gain-of-function phenotype was not caused simply by overexpression of the two mutant receptors.
Interestingly, replacement of Met 145 with either glycine or alanine, two small amino acids lacking large hydrophobic side chains, led to mutant V2 receptors (V2(M145G) and V2(M145A), respectively) that were unable to stimulate Gq5 (Fig. 7A) . However, the V2(M145G) and V2(M145A) mutant receptors, like the V2(M145W) and V2(M145L) constructs, retained the ability to productively interact with Gs5 in a fashion similar to the wt V2 receptor (Fig. 7B and Table II ). This observation excludes the possibility that the inability of the V2(M145G) and V2(M145A) mutant receptors to couple to Gq5 was because of improper folding of the mutant receptor proteins. Table I ). Five l of yeast cell suspensions (absorbance, ϳ0.1) coexpressing the indicated chimeric G proteins and wt or mutant V2 receptors were spotted onto uracil-and histidine-deficient SC medium in the absence or presence of AVP (final concentration, 0.4 M). To suppress background growth, the plates were supplemented with 10 mM AT, a competitive inhibitor of the HIS3 gene product (for details, see "Experimental Procedures"). Plates were incubated at 30°C for 3 days.
TABLE I Mutant V2 vasopressin receptors recovered in a yeast genetic screen that gained coupling to the hybrid G protein Gq5
About 30,000 mutant V2 receptors, generated by random mutagenesis of the region coding for the i2 loop, were screened for their ability to gain coupling to a mutant version of Gpa1 (Gq5) containing the Cterminal ␣ q sequence (for G protein structure, see Fig. 1 ) as described under "Experimental Procedures." The four recovered mutant receptors, RM1-RM4, conferred on the MPY578q5 yeast strain (Fig. 1 ) the ability to grow in an AVP-dependent fashion on plates lacking uracil and histidine (see text for details).
Recovered V2 mutant receptor
Mutations identified via sequencing   RM1  M145W  RM2  M145L, L146R, A147T, S152R  RM3  M145L, Y148F, H155L  RM4 M145⌬, L146W, H150R, S152R (ϭM145W, L146⌬, H150R, S152R)
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the ability to activate yeast Gpa1p. Taken together these data indicate that proper recognition of the C terminus of G␣ q is dependent on the chemical nature of the amino acid present at position 145 in the i2 loop of the V2 vasopressin receptor.
Functional Analysis of RM4-based Mutant V2 Vasopressin Receptors-Sequence analysis showed that Met
145 was deleted in one of the four mutant receptors (RM4) that were recovered in the initial colony screen (Table I ). However, it should be noted that the M145⌬/L146W mutation contained in RM4 (besides the H150R and S152R substitutions) is identical with a M145W/L146⌬ mutation (Table I ). To assess the functional impact of the individual mutations present in RM4, we generated several RM4-based mutant receptors that contained the M145⌬ deletion as the only mutation (note that the M145⌬ deletion is equivalent to a M145L/L146⌬ double mutation) or that contained the mutations present in RM4 in various different combinations (see Table II , center).
Liquid bioassays showed that all mutant receptors that contained the M145⌬ deletion gained coupling to Gq5 as compared with the wt receptor (Figs. 8A and 9A; radioligand, we could only study two representative RM4-based mutant receptors that gained coupling to Gq5) were expressed at levels similar to those found with the wt V2 receptor (Table III) , excluding the possibility that the M145⌬ deletion causes activation of Gq5 due to overexpression of the mutant receptor protein.
TABLE II Amino acid composition and G protein coupling profile of wt and mutant V2 vasopressin receptors expressed in yeast
Numbers refer to amino acid positions in the wt human V2 vasopressin receptor sequence (17) . Liquid bioassays were carried out as described under "Experimental Procedures." Yeast growth was measured in the presence of increasing concentrations of AVP by determining the absorbance at 630 nm. All receptors were expressed in three different yeast strains (MPY578fc, MPY578s5, and MPY578q5) differing only in the structure of the expressed G protein ␣ subunit. MPY578fc expresses wt yeast Gpa1p, whereas MPY578q5 and MPY578s5 carry mutant versions coding for hybrid G␣ subunits (Gq5 and Gs5) in which the last five amino acids of Gpa1p were replaced with the corresponding mammalian G␣ q and G␣ s sequences, respectively (Fig. 1) . EC 50 values were calculated from AVP concentration-response curves using the computer program Kaleidagraph (Synergy Software). Data are given as means Ϯ S.E. of two to seven independent experiments, each carried out in triplicate. 
a E max values were expressed as growth responses relative to the response induced by 0.1 mM AVP in the yeast strain coexpressing the wt V2 receptor and Gs5 (E max ϭ 100%).
b Only residual activity at the highest AVP concentration used (E max Ͻ 10%). c Recreated by site-directed mutagenesis. d Note that RM4 is also equivalent to M145W, L146⌬, H150R, S152R. e Note that M145⌬ is equivalent to the M145L/L146⌬ double mutation. 
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Growth assays also showed that all RM4-based mutant receptors retained the ability to interact with Gs5 with high efficiency in a fashion similar to the wt V2 receptor (Figs. 8B and 9B; Table II, center). Moreover, as observed with the wt receptor, most RM4-based mutant receptors showed little or no coupling to yeast Gpa1p (Figs. 8B and 9C; Table II) . Surprisingly, two RM4-derived mutant receptors, V2(M145⌬) and V2(M145⌬/S152R), displayed substantial coupling to Gpa1p (AVP EC 50 ϳ200 nM, E max ϳ40 -50%) (Fig. 9C and Table II) . Thus, these two mutant receptors were able to interact with all three G proteins used in the present study. Interestingly, in the presence of an additional H150R point mutation, the V2(M145⌬) and V2(M145⌬/S152R) mutant receptors lost the ability to activate Gpa1p but retained coupling to Gs5 and Gq5 (Figs. 8B and 9C; Table II) .
Amino Acids at the Beginning of the i2 Loop Are Critical for Proper Folding of the V2 Vasopressin Receptor-As outlined in the previous paragraph, deletion of Met 145 (which is equivalent to a M145L/L146⌬ double mutation) led to a mutant V2 receptor that displayed promiscuous G protein coupling properties. To examine whether simple shortening of the i2 loop by a single amino acid might be responsible for this phenomenon, we generated eight additional mutant V2 receptors containing single amino acid deletions at positions immediately N-terminal (I141⌬, C142⌬, R143⌬, and P144⌬) and immediately C-terminal of Met 145 (L146⌬, A147⌬, Y148⌬, and R149⌬) (Fig. 2) . Liquid bioassays indicated that the four mutant receptors harboring deletions C-terminal of Met 145 showed essentially the same coupling profile as the wt V2 receptor (Fig. 10 and Table  II) . On the other hand, the four mutant receptors lacking single amino acids N-terminal of Met 145 were completely devoid of functional activity. These mutant receptors were unable to activate either Gs5 (Fig. 10) , Gq5 (Table II) , or yeast Gpa1p (Table II) .
Western blotting studies showed that the four coupling-defective deletion mutants (I141⌬, C142⌬, R143⌬, and P144⌬) were expressed at high levels in yeast that even exceeded the corresponding wt V2 receptor levels (Fig. 4, lanes 1-4) . However, in contrast to the wt receptor, none of the four mutant receptors was able to bind significant amounts of the [ 3 H]SR121463 radioligand (Table III) . Taken together these data strongly suggest that the I141⌬, C142⌬, R143⌬, and P144⌬ deletions disrupt proper folding of the V2 receptor protein.
DISCUSSION
To facilitate structure-function relationship studies of the V2 vasopressin receptor, we expressed the human V2 receptor in yeast strains that required productive receptor/G protein coupling for growth (6, 8 -10, 16) . The yeast strains that we used for these studies only differed in the nature of the G protein ␣ subunit that they expressed (Fig. 1) . Growth assays showed that the V2 vasopressin receptor, which preferentially activates G s in mammalian cells (17) (18) (19) (20) (21) , was unable to couple to the endogenous yeast G protein Gpa1p or a mutant version of Gpa1p in which the last five amino acids of Gpa1p were replaced with the corresponding mammalian G␣ q sequence (Gq5). On the other hand, the V2 receptor was able to productively interact with a hybrid Gpa1p/␣ s subunit (Gs5) in which the last five amino acids were derived from mammalian G␣ s (Fig. 5) . In yeast growth assays, V2 receptor/Gs5 coupling was characterized by remarkably high agonist (AVP) potency (EC 50 ϳ6 nM). The AVP EC 50 value found in yeast was in the same range as AVP EC 50 values determined previously in mammalian systems measuring V2 receptor-mediated stimulation of adenylyl cyclase (17, 19, 21, 36, 38) .
We previously demonstrated (16) that the G q/11 -coupled M 1 , M 3 , and M 5 muscarinic receptors, when expressed in the same yeast strains as used in the present study, were able to activate Gq5 with much higher efficiency (agonist potency) than Gs5, thus displaying a G protein coupling profile that is the reverse of that observed with the V2 vasopressin receptor. These observations indicate that GPCRs maintain their proper G protein coupling selectivity in yeast as studied with yeast Gpa1p/ mammalian G␣ hybrid G proteins. It should be noted that the use of hybrid G␣ subunits for the studies described here was prompted by previous work demonstrating that the last five amino acids of mammalian G␣ subunits play a key role in proper receptor recognition (39, 40) . Most importantly, studies with hybrid mammalian G␣ subunits have shown that the character of the last five G␣ residues largely determines by which class of GPCRs a specific G protein can be activated (for review, see Ref. 4) .
To gain new insight into the molecular mechanisms governing the selectivity of receptor/G protein interactions, we took advantage of the powerful genetic screens that are possible in yeast to isolate mutant V2 receptors endowed with novel G Table II) . Results from one representative experiment carried out with three independent transformants are shown. Data are given as means Ϯ S.E. Two additional experiments gave similar results.
protein coupling properties. Our specific goal was to identify mutant V2 receptors that would gain the ability to activate Gq5, a hybrid G protein containing the C-terminal ␣ q sequence (Fig. 1) . Studies with V1a/V2 hybrid receptors previously showed (21) that the ability of the V1a vasopressin receptor to preferentially recognize G proteins of the G q family is critically dependent on the structural integrity of the i2 loop. Based on this observation, we subjected the i2 loop of the V2 vasopressin receptor to random mutagenesis in an attempt to generate and recover mutant receptors that would gain the ability to activate Gq5 in the yeast expression system.
A yeast genetic screen of about 30,000 mutant receptors (this number is more than sufficient to mutate every amino acid in the i2 loop multiple times) led to the identification of four mutant receptors, RM1-RM4 (Table I) , which, in contrast to the wt receptor, showed pronounced coupling to Gq5 (Fig. 6) . Interestingly, all recovered mutant receptors contained a mutation at position 145, either an amino acid substitution (M145W or M145L) or a deletion (as discussed in more detail below, a M145⌬ deletion is equivalent to a M145L/L146⌬ double mutation). Functional analysis of mutant V2 receptors containing the M145W or M145L amino acid replacements as the only mutations showed that either substitution was able to confer on the V2 receptor the ability to activate Gq5 (Fig. 7A , Table II ). On the other hand, this activity was not observed after replacement of Met 145 with glycine or alanine. These data suggest that the presence of a relatively large hydrophobic amino acid side chain at position 145 favors recognition of the C terminus of G␣ q . This conclusion appears to be inconsistent with our observation that mutant V2 receptors in which Met 145 was deleted also gained the ability to activate Gq5. However, as shown in Fig. 2 , Met 145 is immediately followed by a leucine residue (Leu 146 ) in the wt V2 receptor sequence. As a result, deletion of Met 145 in the wt receptor corresponds to a M145L substitution (which promotes coupling to Gq5) combined with a L146⌬ deletion that does not disrupt V2 receptor function (see below; Fig. 10 and Table II) . Similarly, the RM4 mutant receptor that lacks Met 145 and contains a L146W substitution (be- Table II) . Results from one representative experiment carried out with three independent transformants are shown. Data are given as means Ϯ S.E. Two additional experiments gave similar results.
V2 Vasopressin Receptor Expression in Yeast
sides two additional point mutations; Table I ) is equivalent to a mutant V2 receptor carrying a M145W substitution (which, as discussed above, facilitates coupling to Gq5) and a L146⌬ deletion (which does not interfere with V2 receptor function; Fig. 10 and Table II) .
Whereas the V2 vasopressin receptor is preferentially linked to G s (17) (18) (19) (20) (21) , all other members of the vasopressin/oxytocin receptor family (oxytocin and V1a and V1b vasopressin receptors) are selectively coupled to G q/11 (19 -21) . Interestingly, consistent with our observation that a M145L substitution allows mutant V2 receptors to interact with Gq5, a leucine residue is present in the oxytocin and V1a and V1b vasopressin receptors at the position corresponding to Met 145 in the V2 receptor (Refs. 19 and 21; shown for the V1a receptor in Fig. 2) .
Taken together the above observations strongly support the concept that the presence of a leucine or tryptophan residue at position Met 145 in the V2 receptor facilitates recognition of the C terminus of G␣ q . One possible scenario is that these relatively large hydrophobic residues can directly contact the C terminus of G␣ q that, like the C termini of other G␣ subunits, contains a cluster of hydrophobic amino acids predicted to be involved in receptor recognition (4, 41, 42) . Consistent with this concept, coexpression studies with hybrid M 2 /M 3 muscarinic receptors and hybrid ␣ s /␣ q G proteins suggested that residues within the i2 loop of the G q/11 -coupled M 3 muscarinic receptor may participate in interactions with the C terminus of G␣ q (43) . However, it is likely that additional amino acids located on receptor domains other than the i2 loop, such as the C-terminal portion of the i3 loop and the adjacent cytoplasmic end of TM VI, can also contact C-terminal G␣ residues (40, 44, 45) .
A sequence comparison shows that most GPCRs of the rhodopsin family contain a relatively bulky lipophilic amino acid, such as leucine, isoleucine, phenylalanine, or valine, at the position corresponding to Met 145 in the V2 vasopressin receptor (46, 47 49) showed that the resulting mutant receptors were greatly impaired in their ability to activate G proteins. These loss-of-function mutagenesis data suggested that the targeted i2 loop residue is generally important for productive receptor/G protein coupling (46, 48, 49) . However, the M145A and M145G mutant V2 receptors analyzed in the present study retained the ability to activate the Gs5 G protein with high efficiency (Fig. 7B) , indicating that this concept may not apply to all GPCRs. Importantly, our gain-of-function mutagenesis data indicate that the precise chemical nature of the amino acid present at position 145 (V2 receptor sequence) plays a key role in regulating receptor/G protein coupling selectivity.
The high resolution x-ray structure of bovine rhodopsin indicates that the i2 loop exhibits an L-like structure when viewed parallel to the membrane plane but lacks regular secondary structure (50) . Like the other intracellular loops, the i2 loop does not fold over the area defined by the intracellular ends of TM I-VII (50) . Because the cytoplasmic extension of TM III and the N-terminal segment of the i2 loop show considerable sequence homology among GPCRs of the rhodopsin family (Refs. 46 and 47; Fig. 2) , it is likely that the i2 loop of the V2 receptor adopts a structure similar to that observed in rhodopsin (Fig. 11) . If this assumption is correct, Met 145 (highlighted in magenta in Fig. 11 ) is predicted to be located just N-terminal of the bend of the L-like structure that is a characteristic feature of the i2 loop (50) where it is easily accessible for interactions with G proteins. Interestingly, the V2(M145⌬) and V2(M145⌬/S152R) mutant receptors did not only gain coupling to Gq5 but were also able to activate yeast Gpa1p (Fig. 9C and Table II) . However, coupling of these two mutant receptors to Gpa1p could be selectively disrupted by an additional H150R point mutation (Figs. 8B and 9C; Table II ). This finding further highlights the fact that minor changes in the structure of the i2 loop can lead to pronounced changes in the G protein coupling profile of the V2 vasopressin receptor and probably other GPCRs.
Prompted by the observation that the M145⌬ deletion (which is identical with a M145L/L146⌬ double mutation) had profound effects on the functional properties of the V2 receptor, we studied the G protein coupling properties of additional mutant receptors that lacked single amino acids immediately N-terminal or C-terminal of Met 145 . We found that deletion of single amino acids immediately N-terminal of Met 145 (I141⌬, C142⌬, R143⌬, or P144⌬) resulted in misfolded receptor proteins that were unable to bind ligands and to couple to G proteins (Tables  II and III) . Fig. 11 shows that amino acids Ile 141 -Pro 144 are predicted to be located at the very beginning of the i2 loop structure just adjacent to the cytoplasmic extension of TM III, which also contains the highly conserved DRY(H) motif (Fig. 2) . One possibility therefore is that residues within the Ile 141 -Pro 144 segment are in contact with the cytoplasmic ends of TM III and/or TM V, thus stabilizing the proper arrangement of the transmembrane receptor core. However, the possibility cannot be ruled out that deletions at the beginning of the i2 loop cause major structural rearrangements of the entire i2 loop that may Table II) . Results from one representative experiment carried out with three independent transformants are shown. Data are given as means Ϯ S.E. Two additional experiments gave similar results. disrupt proper receptor folding by mechanisms that are difficult to predict. On the other hand, deletion of single amino acids located C-terminal of Met 145 (L146⌬, A147⌬, Y148⌬, or R149⌬) did not interfere with proper V2 receptor folding and function ( Fig. 10 and Table II ). These residues are located within the central portion of the i2 loop (Fig. 11) and are therefore unlikely to be involved in contacts with the transmembrane receptor core.
It should be noted that all mutant receptors analyzed in this study (except for the L146⌬, A147⌬, Y148⌬, and R149⌬ deletion mutants that were completely devoid of functional activity) retained highly efficient coupling to Gs5 in a fashion similar to the wt receptor (range of AVP EC 50 values, ϳ1-8 nM; Table II ). This observation is consistent with our previous finding (11) that replacement of the i2 loop of the V2 vasopressin receptor with the corresponding V1a vasopressin or SS4 somatostatin receptor sequences (the SS4 receptor is preferentially linked to G i -type proteins) had little effect on the ability of the V2 receptor to productively interact with G s . As shown previously (11, 12) , efficient coupling of the V2 vasopressin receptor to G s is determined primarily by sequence elements within the i3 loop and the membrane-proximal portion of the C-terminal tail. The ability of essentially all analyzed mutant V2 receptors to activate Gs5 with similarly high efficiency (AVP potency) provides a suitable internal control indicating that the lack of coupling FIG. 9 . AVP-induced yeast growth mediated by M145⌬-derived mutant V2 vasopressin receptors to coexpressed wt and hybrid G proteins. Liquid bioassays were carried out with yeast strains coexpressing the indicated M145⌬-derived mutant V2 vasopressin receptors and G protein ␣ subunits (for G protein structures, see Fig. 1 ) as described under "Experimental Procedures." A, coupling to Gq5. The yeast strain coexpressing the wt V2 receptor and Gs5 was included as a control. B, coupling to Gs5. C, coupling to Gpa1p. Yeast growth was measured by determining the absorbance at 630 nm (for AVP EC 50 values, see Table II) . Results from one representative experiment carried out with three independent transformants are shown. Data are given as means Ϯ S.E. Two additional experiments gave similar results. ) had no effect on the G protein coupling properties of the V2 receptor.
to Gq5 displayed by many of the mutant receptors analyzed in this study was not due to generally impaired G protein coupling.
Two recent studies (14, 15) have applied a strategy similar to that described here to identify amino acids located within the transmembrane receptor core that are essential for the proper function of the chemoattractant C5a receptor, another member of the rhodopsin family of GPCRs. Sequence analysis of mutant receptors that retained functional activity suggested possible molecular mechanisms involved in GPCR activation (14) and oligomerization (15) .
In conclusion, our results indicate that receptor random mutagenesis, coupled with yeast expression technology, represents a powerful new approach to study the molecular basis underlying receptor/G protein coupling selectivity. The approach described here, which is applicable to other receptor regions and other classes of GPCRs, should eventually provide a more comprehensive picture of the structural elements regulating the selectivity of receptor/G protein interactions.
